OTCMKTS:PXYN

Praxsyn Stock Forecast, Price & News

$0.0008
0.00 (-11.11 %)
(As of 05/7/2021 10:09 PM ET)
Add
Compare
Today's Range
$0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
$0.01
Volume134,500 shs
Average Volume761,916 shs
Market Capitalization$678,353.60
P/E RatioN/A
Dividend YieldN/A
Beta-1.34
30 days | 90 days | 365 days | Advanced Chart
Receive PXYN News and Ratings via Email

Sign-up to receive the latest news and ratings for Praxsyn and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PXYN
CUSIPN/A
CIKN/A
Phone949-777-6112
Employees66
Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap$678,353.60
Next Earnings DateN/A
OptionableNot Optionable

Headlines

See More Headlines

About Praxsyn

Praxsyn Corporation, a health care company, provides medical practitioners with medications and services for their patients. It formulates non-narcotic and non-habit forming medications using therapeutic and preventative agents in the forms of transdermal creams, patches, and oral capsules for pain management, erectile dysfunction, and metabolic therapies. Praxsyn Corporation provides its products to patients covered under the California workers' compensation system, as well as preferred provider contracts. The company was formerly known as The PAWS Pet Company, Inc. and changed its name to Praxsyn Corporation in March 2014. Praxsyn Corporation was founded in 2005 and is headquartered in Las Vegas, Nevada.

MarketRank

Overall MarketRank

0.62 out of 5 stars

Medical Sector

1368th out of 2,042 stocks

Pharmaceutical Preparations Industry

592nd out of 770 stocks

Analyst Opinion: 0.0Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Praxsyn (OTCMKTS:PXYN) Frequently Asked Questions

What stocks does MarketBeat like better than Praxsyn?

Wall Street analysts have given Praxsyn a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Praxsyn wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Praxsyn?

Praxsyn saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 31,900 shares, an increase of 92.2% from the March 15th total of 16,600 shares. Based on an average daily volume of 538,800 shares, the short-interest ratio is currently 0.1 days.
View Praxsyn's Short Interest
.

How has Praxsyn's stock been impacted by COVID-19?

Praxsyn's stock was trading at $0.0047 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PXYN stock has decreased by 83.0% and is now trading at $0.0008.
View which stocks have been most impacted by COVID-19
.

Who are Praxsyn's key executives?

Praxsyn's management team includes the following people:
  • Mr. Frank J. Brady, Chairman, CEO, Pres & Sec. (Age 46)
  • Mr. Daniel Oswald, Chief Financial Officer
  • Mr. Maxwell Jeffrey Korbin II, Exec. VP & Chief Compliance Officer

Who are some of Praxsyn's key competitors?

What other stocks do shareholders of Praxsyn own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Praxsyn investors own include iBio (IBIO), GenMark Diagnostics (GNMK), Guardion Health Sciences (GHSI), GoGold Resources (GGD), electroCore (ECOR), Danaher (DHR), Co-Diagnostics (CODX), Cleveland BioLabs (CBLI), BIO-key International (BKYI) and BIOLASE (BIOL).

What is Praxsyn's stock symbol?

Praxsyn trades on the OTCMKTS under the ticker symbol "PXYN."

How do I buy shares of Praxsyn?

Shares of PXYN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Praxsyn's stock price today?

One share of PXYN stock can currently be purchased for approximately $0.00.

How much money does Praxsyn make?

Praxsyn has a market capitalization of $678,353.60.

How many employees does Praxsyn have?

Praxsyn employs 66 workers across the globe.

What is Praxsyn's official website?

The official website for Praxsyn is www.praxsyn.com.

Where are Praxsyn's headquarters?

Praxsyn is headquartered at 18011 Sky Park Circle Suite N, Irvine CA, 92614.

How can I contact Praxsyn?

Praxsyn's mailing address is 18011 Sky Park Circle Suite N, Irvine CA, 92614. The company can be reached via phone at 949-777-6112 or via email at [email protected]


This page was last updated on 5/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.